Ritonavir Mylan Unjoni Ewropea - Ungeriż - EMA (European Medicines Agency)

ritonavir mylan

mylan s.a.s - ritonavir - hiv fertőzések - vírusellenes szerek szisztémás alkalmazásra - a ritonavirt más hiv-fertőzött betegek (felnőttek és 2 éves vagy annál idősebb gyermekek) kezelésére más antiretrovirális szerekkel együtt jelzik.

Zydelig Unjoni Ewropea - Ungeriż - EMA (European Medicines Agency)

zydelig

gilead sciences ireland uc - idelalisib - lymphoma, non-hodgkin; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, other antineoplastic agents - zydelig is indicated in combination with an anti‑cd20 monoclonal antibody (rituximab or ofatumumab) for the treatment of adult patients with chronic lymphocytic leukaemia (cll):who have received at least one prior therapy, oras first line treatment in the presence of 17p deletion or tp53 mutation in patients who are not eligible for any other therapies. zydelig is indicated as monotherapy for the treatment of adult patients with follicular lymphoma (fl) that is refractory to two prior lines of treatment.